ESC 365 - Association of anticoagulation with outcomes in patients with infective endocarditis

ESC Professional Premium Access

Association of anticoagulation with outcomes in patients with infective endocarditis

Session: Managing infective endocarditis: guidelines and beyond

Topic: Pharmacotherapy

Speaker: Doctor S. Sheng (Stony Brook, US)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Siyuan Sheng

Stony Brook University Hospital, Stony Brook (United States of America)

0 follower

4 more presentations in this session

Initiation of warfarin is associated with decreased mortality in patients with infective endocarditis: a population based cohort study

Speaker: Mr T. Lee (Hong Kong, HK)

Does the use of anticoagulation or antiplatelet therapy increase cerebrovascular events in patients with infective endocarditis - a systematic review and meta-analysis

Speaker: Doctor M. Diab (Rotenburg An Der Fulda, DE)

Prevalence, profile, causes and prognostic factors of surgical rejection in patients with left-sided infective endocarditis

Speaker: Doctor M. De Miguel (Valladolid, ES)

One-year outcome of elderly patients with endocarditis: a retrospective observational study

Speaker: Doctor F. Marchini (Ferrara, IT)

Access the full session

Managing infective endocarditis: guidelines and beyond

Speakers: Doctor S. Sheng, Mr T. Lee, Doctor M. Diab, Doctor M. De Miguel, Doctor F. Marchini

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources